bimagrumab tirzepatide clinical trial plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 Bimagrumab: a potential anti-obesity drug
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
























